Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.
Noxopharm (ASX:NOX)
Noxopharm passed its final in vivo preclinical safety study for its SOF-SKN drug candidate for autoimmune diseases, with no issues identified, ahead of regulatory submission for the Heracles clinical trial.
Great Western Exploration (ASX:GTE)
Great Western Exploration completed its maiden drilling program at the Sumo niobium target, located within its Yerrida North project in Western Australia.
Swift Networks Group (ASX:SW1)
Swift Networks Group extended the closing date of its entitlement offer by two weeks to May 6, following "significant" global stock market volatility and shareholder requests. The extension allows additional time to receive the entitlement offer material and evaluate the opportunity.
Rincon Resources (ASX:RCR)
Rincon Resources completed a site visit to its Laverton gold project in Western Australia and is now preparing for its first drilling on-ground since 2021.
Aurumin (ASX:AUN)
Aurumin completed reverse circulation drilling at its Johnson Range project, part of the Sandstone gold project in Western Australia. Samples have been finalized and are being transported to the laboratory, with results expected in May.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。